The aim of the trial is to evaluate the effect of somatropin (human growth hormone) on survival (primary end-point; "time to death" and health related quality of life in adult patients on long standing haemodialysis.

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2012
This article has no abstract
Epistemonikos ID: b85e5652bbff7384ace6452463197ea5bb0e172e
First added on: Apr 16, 2025